Latest clinical trials News | Page 41

University of Toronto partners with Moderna to advance research in RNA science and technology
Broadening and scaling reach of mRNA vaccines
Race receives human ethics approval for new trial
MTPConnect announces support for major new resilience projects
Novel acute myeloid leukemia subtypes identified
International partnership may hold key to new cancer therapies
Female hormones could provide clues to higher risk of dementia in women
Our CEO shares his cancer story
Microba announces new research partnership and senior appointment
NCI-COG Pediatric MATCH study shows benefit of genetic screening in refractory tumors
Monash launches flagship biological storage facility: Biobanking Victoria
Monash awarded $23M federal funding as part of $71M Australian Precision Medicine Enterprise project
Locally made medicines
Victorian Biobank Now Globally Recognised
Greater awareness of key bowel cancer risk factors needed, new research finds
New hope for Australians affected by pancreatic cancer
Researchers Outline Bias in Epidemic Research-And Offer New Simulation Tool to Guide Future Work
Cancer Therapeutics CRC/Canthera Discovery next generation drugs land CRA Award for Research Commercialisation
New strategy to preserve insulin-producing cells in diabetes
Researchers honoured with NHMRC leadership awards
Study shows long-term safety of genetically modified immune effector cells
Two distinct tuberculosis subtypes IDed – implications for personalized therapy
In Animal Study, Implant Churns Out CAR-T Cells to Combat Cancer
Best statins for reducing cardiovascular risk in people with diabetes found
Study reveals structure of anti-tumor therapy’s target
Vaxine Pty Ltd fined $13,320 for alleged unlawful advertising of an unapproved Covid vaccine
Large molecule facility doubles size of leading bioanalytical laboratory
Partnership secures Australian-made mRNA vaccines
Researchers lead human trials for malaria vaccine
Blood sample trial to help determine next flu vaccine
New insights on COVID-associated blood clots in people with inherited thrombotic conditions
Potential new Covid immunotherapy could protect vulnerable
Victoria And Abu Dhabi Sign Research And Investment Partnership
Australia and Korea sign MoU on vaccine research
$185 million investment to fast-track treatments for rare and ‘untreatable’ cancers
Backing life-saving local cancer drug development
Better care and treatment for Australians with blood cancer
AI Biotech Lands In Victoria To Advance Early Cancer Detection
New mathematical model predicts effectiveness of Covid vaccines
Boost to funding for R&D trials to find treatments for MND
Many Australian medical researchers not declaring conflicts of interest: Study
Victoria Secures Partnership With Korea On Vaccine Research
Lynparza approved in US as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
Rebrand for Australia’s largest life sciences venture fund
Support for you and your family through pancreatic cancer
Interim Statement on Covid vaccines in context of circulation of Omicron SARS-CoV-2 Variant from WHO Technical Advisory Group 8 March
Cell-based Flucelvax Quad influenza vaccine now approved for Australian children aged two years and older
Covid vaccine rollout worsened existing health inequalities, find researchers